Read the Emergency Use Authorization for LUCIRA^® by Pfizer COVID-19 & Flu Test

Molecular Technology

Technological advancements enable PCR-quality accuracy* and portability¹

See LUCIRA^® by Pfizer COVID-19 & Flu Test in action

Video_id

6353825492112

Account_id

1852113022001

poster

title

flu test in action

autoplay

false

LUCIRA^® by Pfizer COVID-19 & Flu Test leverages advanced nucleic acid amplification technology, similar to RT-PCR¹

The LUCIRA^® by Pfizer COVID-19 & Flu Test provides a level of accuracy* comparable to highly sensitive lab-based PCR tests. Click here for results from the clinical study.

Have more questions about LUCIRA^® by Pfizer COVID-19 & Flu Test?

See FAQs

*The LUCIRA^® by Pfizer COVID-19 & Flu Test provides a level of accuracy comparable to highly sensitive lab-based polymerase chain reaction (PCR) tests. Negative results do not preclude SARS-CoV-2, influenza A, and/or influenza B infection and should not be used as the sole basis for patient management decisions.¹

cDNA, complementary DNA; RNA, ribonucleic acid.

References: 1. LUCIRA^® by Pfizer COVID-19 & Flu Test. Instructions for Use. Pfizer Inc; 2023. 2. Kashir J, Yaqinuddin A. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19. Med Hypotheses. 2020;141:109786. doi:10.1016/j.mehy.2020.109786 3. Chen R, Lu X, Li M, et al. Polymerase chain reaction using “V” shape thermal cycling program. Theranostics. 2019;9(6):1572-1579. doi:10.7150/thno.31986